Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration

被引:45
|
作者
Roh, Miin [1 ]
Selivanova, Alexandra [1 ]
Shin, Hyun Joon [2 ]
Miller, Joan W. [1 ]
Jackson, Mary Lou [3 ]
机构
[1] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA
[2] Harvard Med Sch, Dept Med, VA Boston Hlth Care syst, Div Aging,Brigham & Womens Hosp, Boston, MA USA
[3] VGH Univ British Coumbia, Eye Care Ctr, Vancouver, BC, Canada
来源
PLOS ONE | 2018年 / 13卷 / 05期
关键词
FUNCTION QUESTIONNAIRE; ASSOCIATION; DISABILITY; VALIDITY; THERAPY;
D O I
10.1371/journal.pone.0196481
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. Methods We retrospectively reviewed 47 patients (mean age 83.2 years) with bilateral advanced AMD. Clinical assessment included age, gender, type of AMD, high contrast visual acuity (VA), history of medical conditions, contrast sensitivity (CS), central visual field loss, report of Charles Bonnet Syndrome, current treatment for AMD and Rasch-calibrated NEI VFQ-25 visual function and socioemotional function scales. The NEI VFQ visual function scale includes items of general vision, peripheral vision, distance vision and near vision-related activity while the socioemotional function scale includes items of vision related-social functioning, role difficulties, dependency, and mental health. Multiple regression analysis (structural regression model) was performed using fixed item parameters obtained from the one-parameter item response theory model. Results Multivariate analysis showed that high contrast VA and CS were two factors influencing VRQoL visual function scale (beta = -0.25, 95% CI-0.37 to -0.12, p<0.001 and beta = 0.35, 95% CI 0.25 to 0.46, p<0.001) and socioemontional functioning scale (beta = -0.2, 95% CI -0.37 to -0.03, p = 0.023, and beta = 0.3, 95% CI 0.18 to 0.43, p = 0.001). Central visual field loss was not assoicated with either VRQoL visual or socioemontional functioning scale (beta = -0.08, 95% CI-0.28 to 0.12,p = 0.44 and beta = -0.09, 95% CI -0.03 to 0.16, p = 0.50, respectively). Conclusion In patients with vision impairment secondary to bilateral advanced AMD, high contrast VA and CS are two important factors affecting VRQoL.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Correlates of Good Vision in Eyes With Subfoveal Scars From Neovascular Age-Related Macular Degeneration
    Meshi, Amit
    Camacho, Natalia
    Lin, Tiezhu
    Muftuoglu, Ilkay K.
    Arcinue, Cheryl A.
    Gaber, Raouf
    You, Qi Sheng
    Freeman, William R.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (10) : 765 - 774
  • [42] Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
    Abbas, Abdallah
    O'Byrne, Ciara
    Fu, Dun Jack
    Moraes, Gabriella
    Balaskas, Konstantinos
    Struyven, Robbert
    Beqiri, Sara
    Wagner, Siegfried K.
    Korot, Edward
    Keane, Pearse A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (08) : 2461 - 2473
  • [43] Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration
    Mariani, Alessandro
    Deli, Angeliki
    Ambresin, Aude
    Mantel, Irmela
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (11) : 1635 - 1642
  • [44] Prediction of Post-Treatment Visual Acuity in Age-Related Macular Degeneration Patients With an Interpretable Machine Learning Method
    Kim, Najung
    Lee, Minsub
    Chung, Hyewon
    Kim, Hyung Chan
    Lee, Hyungwoo
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (09):
  • [45] Risk Factors for Discontinuation of Treatment for Neovascular Age-Related Macular Degeneration
    Westborg, Inger
    Rosso, Aldana
    OPHTHALMIC EPIDEMIOLOGY, 2018, 25 (02) : 176 - 182
  • [46] Genetic risk factors for late age-related macular degeneration in India
    Rajendran, Anand
    Dhoble, Pankaja
    Sundaresan, Periasamy
    Saravanan, Vijayan
    Vashist, Praveen
    Nitsch, Dorothea
    Smeeth, Liam
    Chakravarthy, Usha
    Ravindran, Ravilla D.
    Fletcher, Astrid E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (09) : 1213 - 1217
  • [47] Neovascular Age-Related Macular Degeneration Disease Quiescence with Visual Acuity Stability in a Subgroup of Patients Following PRN Treatment
    Fliney, Greg D.
    Zukin, Leonid M.
    Hagedorn, Curtis
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (08) : 604 - 609
  • [48] Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline
    Minami, Sakiko
    Nagai, Norihiro
    Suzuki, Misa
    Kurihara, Toshihide
    Sonobe, Hideki
    Kamoshita, Mamoru
    Uchida, Atsuro
    Shinoda, Hajime
    Takagi, Hitoshi
    Sonoda, Shozo
    Sakamoto, Taiji
    Tsubota, Kazuo
    Ozawa, Yoko
    SCIENTIFIC REPORTS, 2018, 8
  • [49] Towards the validation of quantitative contrast sensitivity as a clinical endpoint: correlations with vision-related quality of life in bilateral AMD
    Vingopoulos, Filippos
    Bannerman, Augustine
    Zhou, Paul
    Koch, Thomas
    Wescott, Hannah E.
    Kim, Leo
    Vavvas, Demetrios
    Miller, Joan W.
    Miller, John B.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (06) : 846 - 851
  • [50] Effect of Vitrectomy for Epiretinal Membrane on Visual Function and Vision-Related Quality of Life
    Okamoto, Fumiki
    Okamoto, Yoshifumi
    Hiraoka, Takahiro
    Oshika, Tetsuro
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (05) : 869 - 874